Mito Health has expanded its direct-to-consumer diagnostics marketplace into seven categories of preventive testing and, according to the company, has run more than one million lab tests.
The company claims its catalog now includes more than 1,000 individual lab tests and panels, at-home test kits shipped nationwide, at-home blood draws in 35 states, imaging and scans such as DEXA and whole-body MRI with coronary artery calcium scoring and VO2 max scheduling, whole genome sequencing at 3x and 30x coverage, specialty gut microbiome and H. pylori kits, and multi-cancer early detection via liquid biopsy.
According to Mito Health, customers can access partner walk-in draw sites nationwide or request at-home draws, pay transparent at-cost prices supported by a $9 per month membership, and use HSA and FSA funds.
The company describes the offering as a single place to order diagnostics without insurance, referrals, or surprise bills and notes plans to add supplements and prescriptions priced the same way.
Mito Health was founded in 2023 and is headquartered in San Francisco.
